Skip to content

Clinical trials

Withdrawn Phase 1/2 Leukemia, Myelomonocytic, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Phase: Phase 1/2 Status: Withdrawn Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Alliance for Clinical Trials in Oncology1
Indiana University1
Rhizen Pharmaceuticals SA1
University of Nebraska1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic6
Leukemia, Myeloid, Acute5
Myelodysplastic Syndromes5
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Congenital Abnormalities3
Leukemia3
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myeloid, Accelerated Phase3
Leukemia, Myeloid, Chronic-Phase3
Lymphoma3

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.